Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Unknown (R10)
Project #
1R10MH053550-01A1
Application #
2253704
Study Section
Special Emphasis Panel (SRCM (21))
Project Start
1995-09-30
Project End
2000-03-31
Budget Start
1995-09-30
Budget End
1997-03-31
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Nathan Kline Institute for Psychiatric Research
Department
Type
DUNS #
167204762
City
Orangeburg
State
NY
Country
United States
Zip Code
10962
Hoptman, Matthew J; Volavka, Jan; Czobor, Pal et al. (2006) Aggression and quantitative MRI measures of caudate in patients with chronic schizophrenia or schizoaffective disorder. J Neuropsychiatry Clin Neurosci 18:509-15
Muller, Daniel J; Klempan, Tim A; De Luca, Vincenzo et al. (2005) The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia. Neurosci Lett 379:81-9
Volavka, Jan; Nolan, Karen A; Kline, Linda et al. (2005) Efficacy of clozapine, olanzapine, risperidone, and haloperidol in schizophrenia and schizoaffective disorder assessed with nurses observation scale for inpatient evaluation. Schizophr Res 76:127-9
Muller, Daniel J; De Luca, Vincenzo; Sicard, Tricia et al. (2005) Suggestive association between the C825T polymorphism of the G-protein beta3 subunit gene (GNB3) and clinical improvement with antipsychotics in schizophrenia. Eur Neuropsychopharmacol 15:525-31
Nolan, Karen A; Volavka, Jan; Czobor, Pal et al. (2005) Aggression and psychopathology in treatment-resistant inpatients with schizophrenia and schizoaffective disorder. J Psychiatr Res 39:109-15
De Luca, Vincenzo; Vincent, John B; Muller, Daniel J et al. (2005) Identification of a naturally occurring 21 bp deletion in alpha 2c noradrenergic receptor gene and cognitive correlates to antipsychotic treatment. Pharmacol Res 51:381-4
Hoptman, Matthew J; Volavka, Jan; Weiss, Elisabeth M et al. (2005) Quantitative MRI measures of orbitofrontal cortex in patients with chronic schizophrenia or schizoaffective disorder. Psychiatry Res 140:133-45
Volavka, Jan; Czobor, Pal; Cooper, Thomas B et al. (2004) Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol. J Clin Psychiatry 65:57-61
Lindenmayer, Jean-Pierre; Czobor, Pal; Volavka, Jan et al. (2004) Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia. J Clin Psychiatry 65:551-6
Volavka, Jan; Kennedy, James L; Ni, Xingqun et al. (2004) COMT158 polymorphism and hostility. Am J Med Genet B Neuropsychiatr Genet 127B:28-9

Showing the most recent 10 out of 16 publications